Bank of Montreal’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-432
Closed -$2K – 5564
2021
Q1
$2K Sell
432
-4,790
-92% -$26.4K ﹤0.01% 4955
2020
Q4
$21K Buy
5,222
+1,890
+57% +$8.08K ﹤0.01% 4412
2020
Q3
$13K Sell
3,332
-571
-15% -$2.37K ﹤0.01% 4051
2020
Q2
$17K Buy
3,903
+1,403
+56% +$8.54K ﹤0.01% 3937
2020
Q1
$13K Sell
2,500
-5,433
-68% -$34.3K ﹤0.01% 3412
2019
Q4
$31K Buy
7,933
+830
+12% +$4.9K ﹤0.01% 4076
2019
Q3
$63K Buy
7,103
+60
+0.9% +$567 ﹤0.01% 3517
2019
Q2
$65K Buy
7,043
+1,506
+27% +$11.3K ﹤0.01% 3572
2019
Q1
$36K Buy
5,537
+4,984
+901% +$32.5K ﹤0.01% 3478
2018
Q4
$5K Buy
553
+405
+274% +$6.09K ﹤0.01% 4137
2018
Q3
$3K Sell
148
-4
-3% -$105 ﹤0.01% 4305
2018
Q2
$4K Buy
+152
New +$4.69K ﹤0.01% 4227
2017
Q4
– Sell
-10,899
Closed -$379K – 4519
2017
Q3
$379K Buy
10,899
+10,799
+10,799% +$347K ﹤0.01% 2397
2017
Q2
$3K Sell
100
-3,000
-97% -$86K ﹤0.01% 4006
2017
Q1
$93K Buy
+3,100
New +$79.1K ﹤0.01% 2855
2014
Q3
– Sell
-12,000
Closed -$110K – 4987
2014
Q2
$110K Buy
12,000
+2,000
+20% +$18.3K ﹤0.01% 2791
2014
Q1
$108K Buy
+10,000
New +$98.1K ﹤0.01% 2769

Other funds holding LJPC

Bank of Montreal's LJPC Position: Q2 2021 in Review

Bank of Montreal sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2021, closing a stake of 432 shares — an estimated $2K sold.

Bank of Montreal first reported a position in LJPC in Q1 2014 and held it in 17 quarters. The position peaked at $379K in Q3 2017. 62 funds tracked by Wall St. Rank hold LJPC as of Q2 2021.

  • Bank of Montreal reported no remaining La Jolla Pharmaceutical Company position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 432 La Jolla Pharmaceutical Company shares in Q2 2021, an estimated $2K.
  • Bank of Montreal first reported a position in La Jolla Pharmaceutical Company in Q1 2014 and held it in 17 quarters.
  • Bank of Montreal's La Jolla Pharmaceutical Company position peaked at $379K in Q3 2017.
  • 62 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.